Jordi Esteve
Barcelona Biomedical Research Park(ES)Hospital Universitari i Politècnic La Fe(ES)Josep Carreras Leukaemia Research Institute(ES)Hospital Clínico Universitario de Valencia(ES)Centro de Investigación Biomédica en Red(ES)Hospital Clínic de Barcelona(ES)Cancer Clinic(US)Biomedical Research Institute(US)Hospital Universitari de Vic(ES)Fundació Clínic per a la Recerca Biomèdica(ES)Centro de Investigación Biomédica en Red de Cáncer(ES)Consorci Institut D'Investigacions Biomediques August Pi I Sunyer(ES)Fundació de Recerca Clínic Barcelona-Institut d’Investigacions Biomèdiques August Pi i Sunyer(ES)Universitat de Barcelona(ES)
Publications by Year
Research Areas
Acute Myeloid Leukemia Research, Acute Lymphoblastic Leukemia research, Chronic Myeloid Leukemia Treatments, Hematopoietic Stem Cell Transplantation, Chronic Lymphocytic Leukemia Research
Most-Cited Works
- → Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia(2020)2,662 cited
- Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups.(2000)
- → Enalapril and Carvedilol for Preventing Chemotherapy-Induced Left Ventricular Systolic Dysfunction in Patients With Malignant Hemopathies(2013)619 cited
- → Cancer incidence and mortality in France over the period 1980–2005(2008)507 cited
- → Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic haematopoietic stem cell transplantation for patients older than 50 years of age with acute myeloblastic leukaemia: a retrospective survey from the Acute Leukemia Working Party (ALWP) of the European group for Blood and Marrow Transplantation (EBMT)(2005)453 cited
- A modified AIDA protocol with anthracycline-based consolidation results in high antileukemic efficacy and reduced toxicity in newly diagnosed PML/RARalpha-positive acute promyelocytic leukemia. PETHEMA group.(1999)